LAKE SUCCESS, N.Y., Feb. 02, 2017 -- Broadridge Financial Solutions, Inc. (NYSE:BR) announced today that its Board of Directors has declared a quarterly cash dividend of $0.33 per share. The dividend is payable on April 3, 2017, to stockholders of record at the close of business on March 14, 2017.
About Broadridge
Broadridge Financial Solutions, Inc. (NYSE:BR) is a leading provider of investor communications and technology-driven solutions for banks, broker-dealers, mutual funds and corporate issuers. Broadridge’s investor and customer communications, securities processing and managed services solutions help clients reduce their capital investments in operations infrastructure, allowing them to increase their focus on core business activities. With over 50 years of experience, Broadridge’s infrastructure underpins proxy voting services for over 90% of public companies and mutual funds in North America, and processes on average over $5 trillion in equity and fixed income trades per day. Broadridge employs approximately 10,000 associates in 16 countries.
For more information about Broadridge, please visit www.broadridge.com.
Contact: Investors: Edings Thibault Investor Relations (516) 472-5129 Media: Gregg Rosenberg Corporate Communications (212) 918-6966


Italy Fines Apple €98.6 Million Over App Store Dominance
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
FDA Approves Mitapivat for Anemia in Thalassemia Patients
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



